Also, a recent study identifies miR-155-mediated loss of C/EBPβ as the mechanism that shifts TGF-β response in breast cancer from growth inhibition to EMT, invasion and metastasis, promoting breast cancer progression. Here, TGFB1 is linked to breast carcinoma.